Wen‐Long Guan

3.9k total citations · 2 hit papers
27 papers, 816 citations indexed

About

Wen‐Long Guan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Wen‐Long Guan has authored 27 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Wen‐Long Guan's work include Gastric Cancer Management and Outcomes (11 papers), Colorectal Cancer Treatments and Studies (6 papers) and Genetic factors in colorectal cancer (6 papers). Wen‐Long Guan is often cited by papers focused on Gastric Cancer Management and Outcomes (11 papers), Colorectal Cancer Treatments and Studies (6 papers) and Genetic factors in colorectal cancer (6 papers). Wen‐Long Guan collaborates with scholars based in China, United States and Germany. Wen‐Long Guan's co-authors include Rui‐Hua Xu, Ye He, Miao‐Zhen Qiu, Caiyun He, Feng‐Hua Wang, Ying Jin, Zhiwei Zhou, Yuhong Li, Yuting Sun and Shi‐Xun Lu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Wen‐Long Guan

26 papers receiving 807 citations

Hit Papers

Gastric cancer treatment:... 2023 2026 2024 2023 2023 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gastric cancer treatment: recent progress and future perspectives
    2023 423 citations Wen‐Long Guan, Ye He et al. Journal of Hematology & Oncology profile →
  2. Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study
    2023 77 citations Gong Chen, Ying Jin et al. ˜The œLancet. Gastroenterology & hepatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wen‐Long Guan 400 309 226 204 189 27 816
Bastiaan P. van Rees 264 0.7× 243 0.8× 171 0.8× 467 2.3× 116 0.6× 20 949
Tsuneaki Fujiya 235 0.6× 387 1.3× 342 1.5× 305 1.5× 265 1.4× 37 954
Chang‐Chieh Wu 275 0.7× 102 0.3× 340 1.5× 233 1.1× 119 0.6× 51 753
Putao Cen 360 0.9× 251 0.8× 226 1.0× 272 1.3× 149 0.8× 38 759
Daichi Ishikawa 289 0.7× 120 0.4× 340 1.5× 207 1.0× 189 1.0× 48 851
Tingting Zhao 177 0.4× 143 0.5× 278 1.2× 89 0.4× 224 1.2× 35 672
Gustaw Lech 218 0.5× 92 0.3× 238 1.1× 118 0.6× 181 1.0× 37 612
Yusuke Amanuma 231 0.6× 198 0.6× 444 2.0× 266 1.3× 326 1.7× 33 876
Biao Fan 259 0.6× 170 0.6× 605 2.7× 418 2.0× 330 1.7× 32 1.2k
Anil K. Rustgi 315 0.8× 165 0.5× 169 0.7× 73 0.4× 93 0.5× 13 559

Countries citing papers authored by Wen‐Long Guan

Since Specialization
Citations

This map shows the geographic impact of Wen‐Long Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Long Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Long Guan more than expected).

Fields of papers citing papers by Wen‐Long Guan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Long Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Long Guan. The network helps show where Wen‐Long Guan may publish in the future.

Co-authorship network of co-authors of Wen‐Long Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Long Guan. A scholar is included among the top collaborators of Wen‐Long Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Long Guan. Wen‐Long Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yilin, Junwei Cui, Yuanyuan Li, et al.. (2025). Rapid quantitative PCR on tongue swabs for pulmonary tuberculosis in adults: a prospective multicentre study. European Respiratory Journal. 65(1). 2401493–2401493. 1 indexed citations
3.
Jin, Ying, Wen‐Long Guan, Zhiqiang Wang, et al.. (2024). A phase II clinical trial of toripalimab in advanced solid tumors with polymerase epsilon/polymerase delta (POLE/POLD1) mutation. Signal Transduction and Targeted Therapy. 9(1). 227–227. 2 indexed citations
4.
Li, Jibin, Wen‐Long Guan, Yuting Sun, et al.. (2024). The optimal threshold of PD-L1 combined positive score to predict the benefit of PD-1 antibody plus chemotherapy for patients with HER2-negative gastric adenocarcinoma: a meta-analysis. Cancer Immunology Immunotherapy. 73(7). 132–132. 7 indexed citations
5.
6.
Sun, Yuting, Shi‐Xun Lu, Wen‐Long Guan, et al.. (2024). Clinical outcomes and biomarker exploration of first-line PD-1 inhibitors plus chemotherapy in patients with low PD-L1-expressing of gastric or gastroesophageal junction adenocarcinoma. Cancer Immunology Immunotherapy. 73(8). 144–144. 9 indexed citations
7.
Wang, Hairong, Yuan Liu, Jiawen Cui, et al.. (2023). Effects of Scutellaria strigillosa Hemsl. extract on HepG2 cell proliferation and apoptosis through binding to aspartate β-hydroxylase. Biochemical and Biophysical Research Communications. 668. 62–69. 3 indexed citations
8.
Guan, Wen‐Long, Ye He, & Rui‐Hua Xu. (2023). Gastric cancer treatment: recent progress and future perspectives. Journal of Hematology & Oncology. 16(1). 57–57. 423 indexed citations breakdown →
9.
Chen, Gong, Ying Jin, Wen‐Long Guan, et al.. (2023). Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study. ˜The œLancet. Gastroenterology & hepatology. 8(5). 422–431. 77 indexed citations breakdown →
10.
Guan, Wen‐Long, Jing Yang, Yuting Sun, et al.. (2023). The relationship between brain metastasis and HER2 expression status in gastric cancer. Clinical & Translational Oncology. 26(3). 765–773. 5 indexed citations
11.
12.
Kang, Shiyang, Yuting Sun, Shi‐Xun Lu, et al.. (2022). Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systemic therapy of gastric cancer. BMC Cancer. 22(1). 1031–1031. 11 indexed citations
13.
Duan, Li, Qiang Wang, Wen‐Long Guan, et al.. (2022). Research on antibody changes and nucleic acid clearance in COVID-19 patients treated with convalescent plasma.. PubMed. 14(4). 2655–2667. 2 indexed citations
14.
Guan, Wen‐Long, Shi‐Xun Lu, Xiaoli Wei, et al.. (2022). Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of Literature. Clinical Medicine Insights Oncology. 16. 1363211146–1363211146. 12 indexed citations
15.
Li, Qifeng, Chao Wu, Jing Zhao, et al.. (2021). ILC2s induce adaptive Th2-type immunity in different stages of tuberculosis through the Notch-GATA3 pathway. International Immunopharmacology. 101(Pt B). 108330–108330. 3 indexed citations
16.
Guan, Wen‐Long, Yuehong Cui, Tianshu Liu, et al.. (2021). The Impact of Mismatch Repair Status on Prognosis of Patients With Gastric Cancer: A Multicenter Analysis. Frontiers in Oncology. 11. 712760–712760. 26 indexed citations
17.
Qiu, Miao‐Zhen, De‐Shen Wang, Yuting Sun, et al.. (2021). PD-1 antibody (Camrelizumab) for metastatic EBV positive gastric cancer: A prospective single-arm, open-label, phase 2 trial.. Journal of Clinical Oncology. 39(15_suppl). e16014–e16014. 2 indexed citations
18.
Guan, Wen‐Long, Miao‐Zhen Qiu, Caiyun He, et al.. (2020). Clinicopathologic Features and Prognosis of BRAF Mutated Colorectal Cancer Patients. Frontiers in Oncology. 10. 563407–563407. 6 indexed citations
19.
Ye, Zu‐Lu, Miao‐Zhen Qiu, Tao Tang, et al.. (2019). Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis. Cancer Medicine. 9(2). 745–756. 31 indexed citations
20.
Qiu, Miao‐Zhen, Caiyun He, Wen‐Long Guan, et al.. (2019). Prospective observation: Clinical utility of plasma Epstein–Barr virus DNA load in EBV‐associated gastric carcinoma patients. International Journal of Cancer. 146(1). 272–280. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bastiaan P. van Rees Breakdown of academic impact, for papers by Tsuneaki Fujiya Breakdown of academic impact, for papers by Chang‐Chieh Wu Breakdown of academic impact, for papers by Putao Cen Breakdown of academic impact, for papers by Daichi Ishikawa Breakdown of academic impact, for papers by Tingting Zhao Breakdown of academic impact, for papers by Gustaw Lech Breakdown of academic impact, for papers by Yusuke Amanuma Breakdown of academic impact, for papers by Biao Fan Breakdown of academic impact, for papers by Anil K. Rustgi
Rankless by CCL
2026